Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rhealth is a biotechnology company that provides health management solutions based on advanced AI through a platform to hospitals.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
Asymmetrex is a life sciences biotechnology company that develops stem cell medicine technology.
Vivasc Therapeutics is a drug development company that specializes in proprietary cardiac targeting peptide platform technology.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Respair is a medical device company that creates cutting-edge airway products to help clinicians and patients in critical care settings.
Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Safi Biosolutions is biotechnology based company.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Life sciences R&D, consulting and investment
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Lazzaro Medical is to assist the millions of patients who have tracheobronchomalacia (TBM).
Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease.
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.
Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics.
WynnVision is a technology based company.
VoluMetrix is dedicated to developing breakthrough monitoring technologies to enhance people's well-being.
Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.
Vivita Technologies develops biomaterials for regenerative medicine, intending to alleviate the scarcity of donor organs and tissues.
Ontogen Medtech is a medical device development firm.
Biotricity is a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease.
Lung and Blood Institute has invested in 55 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lung and Blood Institute's top investment sectors include Biotechnology, Health Care, Medical Device, Medical, Life Science. The firm invests across 25 different industry categories.
Among tracked funding rounds, Cartesian Therapeutics received $130.0M in a Post Ipo Equity round. Lung and Blood Institute's total known invested capital is $198.9M.
Lung and Blood Institute's average investment size is $4.6M across its portfolio of 55 companies.
Recent Lung and Blood Institute portfolio additions include Rhealth, EydisBio, Asymmetrex, Vivasc Therapeutics, Microvascular Therapeutics. These companies were founded in 2020 or later.